ID
29662
Description
Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Physical Examination: Vital Signs, pedal oedema. Time: Treatment Period 1, Day 28, pre-dose.
Link
https://clinicaltrials.gov/ct2/show/NCT00318630
Keywords
Versions (1)
- 4/10/18 4/10/18 - Sarah Riepenhausen
Copyright Holder
GlaxoSmithKline
Uploaded on
April 10, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Influence of PPAR gamma agonist vs. Placebo on allergen-induced late asthmatic response NCT00318630
Physical examination - Treatment Period 1, Day 28, Pre-dose
- StudyEvent: ODM
Description
Pedal Oedema
Alias
- UMLS CUI-1
- C0574002
Description
Date of Assessment
Data type
date
Alias
- UMLS CUI [1]
- C2985720
Description
Hr : Min (00:00 - 23:59)
Data type
time
Alias
- UMLS CUI [1,1]
- C1516048
- UMLS CUI [1,2]
- C0040223
Description
Note: Use the same ankle throughout the study.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C0205125
Description
Side of assessed ankle
Data type
integer
Alias
- UMLS CUI [1,1]
- C0574002
- UMLS CUI [1,2]
- C0441987
Similar models
Physical examination - Treatment Period 1, Day 28, Pre-dose
- StudyEvent: ODM
C0038846 (UMLS CUI [1,2])
C0038846 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0205125 (UMLS CUI [1,2])
C0441987 (UMLS CUI [1,2])
No comments